2
Announcements
Trials
Browse
Landscape
Status
No longer available
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
12
Expanded_access
2
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Conditions
Urogenital Neoplasms
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Interventions
3-Iodobenzylguanidine
9
Amifampridine
6
nilotinib
5
Magnetic Resonance Spectroscopy
5
Cyclophosphamide
5
trametinib
4
pembrolizumab
4
gallium 68 PSMA-11
4
fludarabine
4
elotuzumab
4
dabrafenib
4
Nivolumab
4
Bortezomib
4
Afatinib
4
venetoclax
3
regorafenib
3
midostaurin
3
fludarabine phosphate
3
TIC10 compound
3
Sunitinib
3
Prednisone
3
Lenalidomide
3
Ipilimumab
3
Everolimus
3
Dexamethasone
3
Crizotinib
3
Capecitabine
3
Axitinib
3
Alpelisib
3
Abiraterone Acetate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Expanded_access
×
Suspensions
×
Clear all
NCT03756311
2026-01-23
Expanded Access to NanoPac
NanOlogy, LLC
No longer available
NCT04060628
2026-01-23
Expanded Access to NanoDoce
NanOlogy, LLC
No longer available